Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Blankestijn

Showing results (111-120 of 262) with videos related to

Pageof 27
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 12, 2013
Time-averaged level of fibroblast growth factor-23 and clinical events in chronic kidney diseaseAnnet Bouma-de Krijger, Michiel L Bots, Marc G Vervloet, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 11, 2020
Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablationRaymond R Townsend, Antony Walton, Douglas A Hettrick, et al.
Plos One|February 7, 2015
A systematic review concerning the relation between the sympathetic nervous system and heart failure with preserved left ventricular ejection fractionWillemien L Verloop, Martine M A Beeftink, Bernadet T Santema, et al.
BMC Nephrology|June 17, 2021
Von Willebrand factor, ADAMTS13 and mortality in dialysis patientsGurbey Ocak, Mark Roest, Marianne C Verhaar, et al.
Journal of Hypertension|June 8, 2013
Eligibility for percutaneous renal denervation: the importance of a systematic screeningWillemien L Verloop, Eva E Vink, Michiel Voskuil, et al.
Seminars in Dialysis|January 25, 2005
Resolving controversies regarding hemodiafiltration versus hemodialysis: the Dutch Convective Transport StudyE Lars Penne, Peter J Blankestijn, Michiel L Bots, et al.
Journal of Hypertension|August 4, 2018
Prevalence of potential modifiable factors of hypertension in patients with difficult-to-control hypertensionNicolette G C Van Der Sande, Peter J Blankestijn, Frank L J Visseren, et al.
American Heart Journal|May 30, 2021
Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medicationsFelix Mahfoud, Michael Weber, Roland E Schmieder, et al.
American Journal of Physiology. Renal Physiology|January 4, 2007
End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cellsPeter E Westerweel, Imo E Hoefer, Peter J Blankestijn, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 20, 2010
Progenitor cells and vascular function are impaired in patients with chronic kidney diseaseKim E Jie, Masha A Zaikova, Marloes W T Bergevoet, et al.
Pageof 27

Showing results (111-120 of 262) with videos related to

Sort By:
Pageof 27
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 12, 2013
Time-averaged level of fibroblast growth factor-23 and clinical events in chronic kidney diseaseAnnet Bouma-de Krijger, Michiel L Bots, Marc G Vervloet, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 11, 2020
Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablationRaymond R Townsend, Antony Walton, Douglas A Hettrick, et al.
Plos One|February 7, 2015
A systematic review concerning the relation between the sympathetic nervous system and heart failure with preserved left ventricular ejection fractionWillemien L Verloop, Martine M A Beeftink, Bernadet T Santema, et al.
BMC Nephrology|June 17, 2021
Von Willebrand factor, ADAMTS13 and mortality in dialysis patientsGurbey Ocak, Mark Roest, Marianne C Verhaar, et al.
Journal of Hypertension|June 8, 2013
Eligibility for percutaneous renal denervation: the importance of a systematic screeningWillemien L Verloop, Eva E Vink, Michiel Voskuil, et al.
Seminars in Dialysis|January 25, 2005
Resolving controversies regarding hemodiafiltration versus hemodialysis: the Dutch Convective Transport StudyE Lars Penne, Peter J Blankestijn, Michiel L Bots, et al.
Journal of Hypertension|August 4, 2018
Prevalence of potential modifiable factors of hypertension in patients with difficult-to-control hypertensionNicolette G C Van Der Sande, Peter J Blankestijn, Frank L J Visseren, et al.
American Heart Journal|May 30, 2021
Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medicationsFelix Mahfoud, Michael Weber, Roland E Schmieder, et al.
American Journal of Physiology. Renal Physiology|January 4, 2007
End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cellsPeter E Westerweel, Imo E Hoefer, Peter J Blankestijn, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 20, 2010
Progenitor cells and vascular function are impaired in patients with chronic kidney diseaseKim E Jie, Masha A Zaikova, Marloes W T Bergevoet, et al.
Pageof 27